New front developing in war on killer bugs

(Correction: Because of a reporting error, a story in yesterday's Business & Innovation section incorrectly characterized estimates associated with a new drug to combat Staphylococcus aureus in the bloodstream. Cubist Pharmaceuticals estimates the US market for treatments of the disease to be $1 billion.) (Full article: 1214 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly